XML 57 R7.htm IDEA: XBRL DOCUMENT v3.24.1
CORPORATE INFORMATION
 12 Months Ended
Dec. 31, 2023
Disclosure of subsidiaries [abstract]  
CORPORATE INFORMATION CORPORATE INFORMATION
Legend Biotech Corporation, (the "Company"), was incorporated on May 27, 2015 as an exempted company in the Cayman Islands with limited liability under the Companies Act (As Revised) of the Cayman Islands. The registered office address of the Company is PO Box 10240, Harbour Place, 103 South Church Street, George Town, Grant Cayman KY1-1002, Cayman Islands.

Legend Biotech Corporation is an investment holding company. The Company’s subsidiaries are principally engaged in the discovery, and development, manufacturing and commercialization of novel cell therapies for oncology and other indications.
In the opinion of the Company's Board of Directors, the ultimate holding company of Legend Biotech Corporation, a Cayman Islands corporation, is Genscript Corporation (“Genscript Corp”), which was incorporated in the United States of America.
Information about subsidiaries
CompanyPlace and date
of
incorporation		Issued ordinary
shares/paid-up
capital		Percentage of equity
interest attributable
to the Company		Principal
activities
Direct %Indirect %
Legend Biotech Limited (“Legend BVI”)The British Virgin Islands June 2, 2015US$2,453,819,239 100 — Investment holding
Legend Biotech HK Limited (“Legend HK”)Hong Kong June 3, 2015US$2,453,819,239 — 100 Investment holding
Nanjing Legend Biotechnology Co., Ltd. (“Legend Nanjing”)PRC* November 17, 2014US$212,500,000 — 100 Manufacture and sale of life sciences research products; performance and sale of research and development services
Legend Biotech USA Incorporated (“Legend USA”)Delaware, United States of America August 31, 2017— — 100 Manufacture and sale of life sciences products; performance of life sciences research and development
Legend Biotech Ireland Limited (“Legend Ireland”)Ireland November 13, 2017US$2,217,445,234 — 100 Manufacture and sale of life sciences products; performance of life sciences research and development; treasury center for Legend Biotech
Legend Biotech Belgium B.V. (“Legend Belgium”)Belgium June 23, 2021US$46,177,685 — 100 Manufacture and sale of life sciences products
Hainan Chuanji Biotechnology Co., Ltd. (“Hainan Chuanji”)PRC October 25, 2021— — 100 General & administrative
** The People’s Republic of China (the “PRC” or “China”), including the Hong Kong Special Administrative Region of China (“Hong Kong”).